| 000 | 01347 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511162607.0 | ||
| 264 | 0 | _c19770321 | |
| 008 | 197703s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000225129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEagan, R T | |
| 245 | 0 | 0 |
_aEvaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer. _h[electronic resource] |
| 260 |
_bOncology _c1976 |
||
| 300 |
_a146-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEtoposide _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aPodophyllotoxin _xanalogs & derivatives |
| 650 | 0 | 4 | _aRemission, Spontaneous |
| 650 | 0 | 4 |
_aVincristine _xadverse effects |
| 700 | 1 | _aAhmann, D L | |
| 700 | 1 | _aBisel, H F | |
| 773 | 0 |
_tOncology _gvol. 33 _gno. 3 _gp. 146-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000225129 _zAvailable from publisher's website |
| 999 |
_c1020117 _d1020117 |
||